Directors' dealings and addit

RNS Number : 3250U
Plant Health Care PLC
13 May 2008
 

13 May 2008

For Immediate Release





PLANT HEALTH CARE PLC (THE 'COMPANY')

Directors' dealings and additional listing



On 12 May 2008, pursuant to the exercise of options by John Brady, Chief Executive, the Company approved the allotment and issue credited as fully paid of 50,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares'), details as follows:


Name of option holder

Number of shares over which option exercised

Option price per share

John A. Brady

50,000

37p


The Company was subsequently advised that, on 12 May 2008, John Brady sold 50,000 Ordinary Shares at a price of 340 pence per share.  


The Company was also advised on 12 May 2008 that Dr. Albert Fischer, Chairman, sold 25,000 Ordinary Shares at a price of 340 pence per share.  


Following the above-mentioned allotment and disposals, the interests of Dr. Albert Fischer and John Brady in the ordinary share capital of the Company are as shown below:


Name

Ordinary Share holding

Percentage of issued Ordinary Share capital

Share Options

LTIPs

Dr. Albert Fischer

129,736

0.29%

225,000

Nil

John Brady

14,395

0.032%

1,150,000

200,000


Application has been made for 50,000 Ordinary Shares (the 'New Shares') to be admitted to trading on the London Stock Exchange's AIM market for listed securities ('Admission').


The New Shares are being issued pursuant to the exercise of options. Admission is expected to become effective on 19 May 2008. The New Shares will rank pari passu with the Company's existing Ordinary Shares.  


Following admission of the New Shares, the total issued share capital of the Company will be 44,801,798 Ordinary Shares, all of which have voting rights.  


The above figure 44,801,798 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.  


Enquiries:


Andrew C. Wood FCIS 

Company Secretary  

020 8866 5702


Evolution Securities Limited

Tim Worlledge/Tim Redfern  

Tel: 020 7071 4300  


Tavistock Communications

Jeremy Carey/Matt Ridsdale

Tel: 020 7920 3150



END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAASDFDLPEFE
UK 100